By Andy Extance2019-07-29T14:30:00
Source: © Science Photo Library
Upregulated gene triggers laminin-α1 protein production, reviving paralysed limbs
Researchers in Canada and Sweden have used a novel Crispr system to reverse harm caused by muscular dystrophy – usually thought to be permanent – in mice. Pre-clinical studies often treat animals early, before symptoms can be detected, says Ronald Cohn, senior scientist, president and chief executive officer of The Hospital for Sick Children in Toronto.
Site powered by Webvision Cloud